Hapbee Announces Partnership with Gharieni Group To License and Distribute Hapbee’s Wellness Technology in Europe and The Middle East
Hapbee Technologies (HAPBF) has formed a strategic partnership with Gharieni Group to distribute Hapbee's Enterprise Solutions for Spa and Wellness across Europe and the Middle East. The collaboration will integrate Hapbee's bio-streaming wellness technology into Gharieni's premium spa equipment.
As the global wellness industry reaches a $5 trillion valuation, this partnership aims to provide hospitality operators with turnkey solutions for enhanced guest experiences and new revenue streams. The agreement includes retrofitting existing equipment through Hapbee's Mattress Toppers and Sleep Pads.
The partnership also introduces a retail program allowing properties to offer consumer versions for at-home use. As part of the agreement, Hapbee will settle license fees of $489,388 USD owed to Emulate Therapeutics through the issuance of 10.5 million subordinate voting shares.
Hapbee Technologies (HAPBF) ha formato una partnership strategica con Gharieni Group per distribuire le Soluzioni Enterprise di Hapbee per Spa e Benessere in Europa e Medio Oriente. La collaborazione integrerà la tecnologia di bio-streaming per il benessere di Hapbee negli apparecchi spa premium di Gharieni.
Con l'industria globale del benessere che raggiunge una valutazione di 5 trilioni di dollari, questa partnership mira a fornire agli operatori dell'ospitalità soluzioni chiavi in mano per migliorare l'esperienza degli ospiti e generare nuovi flussi di entrate. L'accordo prevede l'adeguamento delle attrezzature esistenti tramite i Materassi e i Cuscini per il Sonno di Hapbee.
La partnership introduce anche un programma di vendita al dettaglio che consente alle strutture di offrire versioni consumer per l'uso domestico. Come parte dell'accordo, Hapbee pagherà le commissioni di licenza di 489.388 USD dovute a Emulate Therapeutics attraverso l'emissione di 10,5 milioni di azioni di voto subordinate.
Hapbee Technologies (HAPBF) ha formado una asociación estratégica con Gharieni Group para distribuir las Soluciones Empresariales de Hapbee para Spa y Bienestar en Europa y Medio Oriente. La colaboración integrará la tecnología de bio-streaming de bienestar de Hapbee en el equipo de spa premium de Gharieni.
A medida que la industria global del bienestar alcanza una valoración de 5 billones de dólares, esta asociación tiene como objetivo proporcionar a los operadores de hospitalidad soluciones llave en mano para mejorar la experiencia de los huéspedes y generar nuevos flujos de ingresos. El acuerdo incluye la adaptación del equipo existente a través de los Colchones y Almohadillas de Sueño de Hapbee.
La asociación también introduce un programa minorista que permite a las propiedades ofrecer versiones para consumidores para uso en casa. Como parte del acuerdo, Hapbee pagará las tarifas de licencia de 489,388 USD adeudadas a Emulate Therapeutics mediante la emisión de 10.5 millones de acciones de voto subordinadas.
Hapbee Technologies (HAPBF)는 Gharieni Group와 전략적 파트너십을 체결하여 유럽 및 중동에서 Hapbee의 스파 및 웰니스 기업 솔루션을 배포합니다. 이 협력은 Hapbee의 바이오 스트리밍 웰니스 기술을 Gharieni의 프리미엄 스파 장비에 통합할 것입니다.
글로벌 웰니스 산업이 5조 달러의 가치에 도달함에 따라, 이 파트너십은 호스피탈리티 운영자에게 향상된 고객 경험과 새로운 수익원을 위한 턴키 솔루션을 제공하는 것을 목표로 합니다. 계약에는 Hapbee의 매트리스 토퍼와 수면 패드를 통해 기존 장비를 개조하는 내용이 포함됩니다.
이 파트너십은 또한 시설이 가정용 소비자 버전을 제공할 수 있는 소매 프로그램을 도입합니다. 계약의 일환으로 Hapbee는 489,388 USD의 라이센스 수수료를 Emulate Therapeutics에 지급하기 위해 1,050만 개의 종속 투표 주식을 발행할 것입니다.
Hapbee Technologies (HAPBF) a formé un partenariat stratégique avec Gharieni Group pour distribuer les Solutions Entreprise de Hapbee pour les Spa et le Bien-être à travers l'Europe et le Moyen-Orient. La collaboration intégrera la technologie de bio-streaming de bien-être de Hapbee dans l'équipement de spa premium de Gharieni.
Alors que l'industrie mondiale du bien-être atteint une évaluation de 5 trillions de dollars, ce partenariat vise à fournir aux opérateurs hôteliers des solutions clé en main pour améliorer l'expérience des clients et générer de nouveaux flux de revenus. L'accord comprend la modernisation de l'équipement existant grâce aux Matelas et Tapis de Sommeil de Hapbee.
Le partenariat introduit également un programme de vente au détail permettant aux établissements d'offrir des versions pour consommateurs à utiliser à domicile. Dans le cadre de l'accord, Hapbee réglera des frais de licence de 489 388 USD dus à Emulate Therapeutics par l'émission de 10,5 millions d'actions de vote subordonnées.
Hapbee Technologies (HAPBF) hat eine strategische Partnerschaft mit Gharieni Group gebildet, um die Unternehmenslösungen von Hapbee für Spa und Wellness in Europa und dem Nahen Osten zu vertreiben. Die Zusammenarbeit wird die Bio-Streaming-Wellnesstechnologie von Hapbee in die Premium-Spa-Ausrüstung von Gharieni integrieren.
Da die globale Wellness-Branche eine Bewertung von 5 Billionen Dollar erreicht, zielt diese Partnerschaft darauf ab, Hospitality-Betreibern schlüsselfertige Lösungen für verbesserte Gästeerlebnisse und neue Einnahmequellen anzubieten. Die Vereinbarung umfasst die Nachrüstung bestehender Geräte durch Hapbees Matratzenauflagen und Schlafpads.
Die Partnerschaft führt auch ein Einzelhandelsprogramm ein, das es Einrichtungen ermöglicht, Verbraucher-Versionen für den Hausgebrauch anzubieten. Im Rahmen der Vereinbarung wird Hapbee die Lizenzgebühren in Höhe von 489.388 USD, die an Emulate Therapeutics geschuldet werden, durch die Ausgabe von 10,5 Millionen nachrangigen stimmberechtigten Aktien begleichen.
- Exclusive distribution agreement in Europe and Middle East markets
- Integration into premium spa equipment expands market reach
- New revenue stream through retail program for at-home consumer products
- Partnership with established 30+ year industry leader
- Share dilution through issuance of 10.5 million new shares
- Significant license fee payment of $489,388 USD to Emulate Therapeutics
Collaboration Will Bring Enhanced Guest Experiences and New Revenue Streams to Hotels, Spas & Wellness Clinics
VANCOUVER, British Columbia, April 03, 2025 (GLOBE NEWSWIRE) -- Hapbee Technologies, Inc. (TSXV: HAPB) (OTCQB: HAPBF), the leader in bio-streaming wellness technology, has announced a strategic partnership with Gharieni Group, a leading international manufacturer of premium-quality spa tables, treatment beds and equipment. Under the terms of the agreement, Gharieni becomes the exclusive distributor of Hapbee's Enterprise Solutions for Spa and Wellness across Europe and the Middle East.
As global wellness continues its rapid expansion—now valued at over USD
Gharieni's deep market penetration and strong brand equity in Europe and the Middle East position them as an ideal partner to scale Hapbee's distribution in key luxury wellness markets. With a 30+ year legacy of innovation, Gharieni is globally recognized for redefining treatment experiences through state-of-the-art spa and wellness treatment beds, loungers, and integrative technologies.
This collaboration enables the seamless integration of Hapbee's bio-streaming technology into Gharieni's premium spa beds, tables and loungers, as well as the option to retrofit existing equipment through Hapbee's Mattress Toppers and Sleep Pads.
“This alliance significantly strengthens our commercial capabilities in Europe and the Middle East,” said Yona Shtern, CEO of Hapbee. “By embedding our technology into Gharieni's globally recognized equipment, we can better serve the increasing demand for integrated wellness solutions from both guests and operators.”
For Gharieni, the partnership expands their offering into digital wellness, reinforcing their leadership as a solutions provider at the convergence of hospitality and wellness technology.
“Wellness is a core pillar of guest experience,” said Sammy Gharieni, Founder & CEO of Gharieni Group. “Our partnership with Hapbee introduces a novel layer of personalization and functionality to our equipment, making it easier for operators to address evolving market demands.”
Importantly, the agreement also opens significant new revenue opportunities for hospitality operators. In addition to in-spa and in-room applications for enhanced relation and optimized sleep, properties will be able to leverage Hapbee’s retail program, offering consumer versions of the technology for at-home use. This enables continuous engagement with guests beyond their stay, while contributing to the property's bottom line by converting consumer trial on property in retail sales and profits.
Hapbee will be featured alongside Gharieni at upcoming Spa, Wellness and Hospitality exhibitions where industry stakeholders can experience the integrated solution firsthand.
The Company agreed to the settlement of an aggregate of license fees owed Emulate Therapeutics Inc. in the sum of Four Hundred Eighty-Nine Thousand Three Hundred Eighty Eight Dollars USD (
About Gharieni Group
Gharieni Group is a global leader in premium spa and wellness technologies and medical treatment equipment, serving luxury hotels, spas, and wellness centers in over 120 countries. Recognized for its precision engineering and forward-thinking design, Gharieni continues to shape the future of wellness infrastructure.
About Hapbee Technologies, Inc.
Hapbee (TSXV: HAPB) (OTCQB: HAPBF) is a leading provider of bio-streaming wellness technology. Designed to help users improve focus, relaxation, and sleep without ingesting substances, Hapbee's technology is used in hospitality, fitness, and personal wellness applications globally. Hapbee is available for consumer purchase at Hapbee.com and Target.com.
Forward-Looking Information Disclaimer
Certain statements included in this news release constitute forward-looking information or statements (collectively, "forward-looking statements"), including those identified by the expressions "anticipate", "believe", "plan", "estimate", "expect", "intend", "may", "should" and similar expressions to the extent they relate to the Company or its management. The forward-looking statements are not historical facts but reflect current expectations regarding future results or events. This news release contains forward-looking statements. These forward-looking statements are based on current expectations and various estimates, factors and assumptions and involve known and unknown risks, uncertainties and other factors. Forward- looking statements are not guarantees of future performance and involve risks, uncertainties and assumptions which are difficult to predict. Such statements and information are based on numerous assumptions regarding the Company’s ability to meet its planned product marketing and development initiatives.
Factors that could cause the actual results to differ materially from those in the forward-looking statements include, delays in design, production, manufacturing, development or releases of signal blends, collection of data from customer use, or the Company may not be able to achieve its targets as anticipated or at all; changes in legislation and regulations; increase in operating costs; equipment failures; failure of counterparties to perform their contractual obligations; litigation; the loss of key directors, employees, advisors or consultants and fees charged by service providers.
Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. These risks, uncertainties and assumptions include, but are not limited to, those described in Hapbee's annual information form dated May 6, 2024, a copy of which is available on SEDAR at www.sedar.com, and could cause actual events or results to differ materially from those projected in any forward-looking statements.
These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Readers should not place undue reliance on the Company's forward-looking statements.
Neither TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSX-V) accepts responsibility for the adequacy or accuracy of this release.
For further information contact: Andrea Hamilton
T: 1 888-841-7086
W: www.hapbee.com
Andrea@TheoryComm.com
FAQ
What is the value of the global wellness industry that Hapbee (HAPBF) is targeting?
How will HAPBF settle its license fees with Emulate Therapeutics?
What products will Gharieni distribute for HAPBF in Europe and Middle East?
How will the HAPBF partnership generate revenue for hospitality operators?
